Key result
A patient with pulmonary artery angiosarcoma who underwent radical resection followed by chemotherapy survived for 6 years.
Why the study?
Does a multidisciplinary approach including radical surgery and chemoradiotherapy improve survival in patients with pulmonary artery angiosarcoma?
Case Report (n=1)
Does a multidisciplinary approach including radical surgery and chemoradiotherapy improve survival in patients with pulmonary artery angiosarcoma?
A multidisciplinary approach including radical surgery and adjuvant chemoradiotherapy can lead to long-term survival (6 years) in patients with rare pulmonary artery angiosarcoma.
Authors
No takes yet. Share an insight, caveat, or question.
Supports multidisciplinary management in rare pulmonary artery angiosarcoma; leaves open need for prospective validation in larger cohorts.
Chaubey et al. (2012) conducted a case report in pulmonary artery angiosarcoma (n=1). Radical resection followed by chemotherapy was evaluated on Survival. A patient with pulmonary artery angiosarcoma who underwent radical resection followed by chemotherapy survived for 6 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: